(Q53073357)

English

First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2,251 patients.

scientific article published on 5 September 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20819780%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2,251 patients (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20819780%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

metastatic breast cancer

1 reference

based on heuristic

inferred from title

Laura Biganzoli

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20819780%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20819780%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Daniil Stroyakovskiy

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20819780%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Tadeusz Pieńkowski

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20819780%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20819780%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

I E Smith

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20819780%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

J-Y Pierga

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20819780%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

H Cortés-Funes

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20819780%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

C Thomssen

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20819780%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

A Fabi

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20819780%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

B Xu

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20819780%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

F A Franke

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20819780%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

B Kaufman

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20819780%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

P Mainwaring

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20819780%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

B De Valk

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20819780%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

J L González-Trujillo

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20819780%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

I Koza

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20819780%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

K Petrakova

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20819780%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

D Pereira

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20819780%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

K I Pritchard

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20819780%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

ATHENA Study Group

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20819780%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

5 September 2010

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20819780%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Annals of Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20819780%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

22

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20819780%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20819780%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

595-602

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20819780%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

The function of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ430

21 January 2018

The biology of VEGF and its receptors

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ430

21 January 2018

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ430

21 January 2018

Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ430

21 January 2018

Independent review of E2100: a phase III trial of bevacizumab plus paclitaxel versus paclitaxel in women with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ430

21 January 2018

Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ430

21 January 2018

Risk of gastrointestinal perforation in patients with cancer treated with bevacizumab: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ430

21 January 2018

Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ430

21 January 2018

Clinical outcomes associated with bevacizumab-containing treatment of metastatic colorectal cancer: the BRiTE observational cohort study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ430

21 January 2018

Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ430

21 January 2018

Gemcitabine plus Paclitaxel versus Paclitaxel monotherapy in patients with metastatic breast cancer and prior anthracycline treatment

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ430

21 January 2018

Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ430

21 January 2018

Identifiers

10.1093/ANNONC/MDQ430

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20819780%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20819780%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53073357&oldid=1672302629"